These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26050376)

  • 1. From addiction to infection: managing drug abuse in the context of HIV/AIDS in Africa.
    Akindipe T; Abiodun L; Adebajo S; Lawal R; Rataemane S
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):47-54. PubMed ID: 26050376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Abuja +12 declaration: implications for HIV response in Africa.
    Mburu RW; Folayan MO; Akanni O
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):34-46. PubMed ID: 26050375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.
    Santibanez SS; Garfein RS; Swartzendruber A; Purcell DW; Paxton LA; Greenberg AE
    J Urban Health; 2006 Jan; 83(1):86-100. PubMed ID: 16736357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Female prostitution and HIV/AIDS--review of the literature on epidemiology and personal observations in a contact center for drug dependent patients].
    Marquart KH
    Gesundheitswesen; 1994 Nov; 56(11):617-21. PubMed ID: 7819675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature.
    Grenfell P; Baptista Leite R; Garfein R; de Lussigny S; Platt L; Rhodes T
    Drug Alcohol Depend; 2013 May; 129(3):180-209. PubMed ID: 23306095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meth/amphetamine use and associated HIV: Implications for global policy and public health.
    Degenhardt L; Mathers B; Guarinieri M; Panda S; Phillips B; Strathdee SA; Tyndall M; Wiessing L; Wodak A; Howard J;
    Int J Drug Policy; 2010 Sep; 21(5):347-58. PubMed ID: 20117923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social context of needle selling in Baltimore, Maryland.
    Latkin CA; Davey MA; Hua W
    Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
    Lima ES; Bastos FI; Telles PR; Friedman SR
    Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of risk-taking behaviors, HIV and AIDS knowledge, and risk perception among young males in southwest China.
    Wu Z; Zhang J; Detels R; Li VC; Cheng H; Duan S; Li Z; Dong L; Huang S; Jia M; Bi X
    AIDS Educ Prev; 1997 Apr; 9(2):147-60. PubMed ID: 9167800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Government priorities for preventing HIV / AIDS.
    Ainsworth M
    AIDS Anal Afr; 1998 Aug; 8(4):10-4. PubMed ID: 12294025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise.
    Ball AL
    Int J Drug Policy; 2007 Aug; 18(4):241-5. PubMed ID: 17689371
    [No Abstract]   [Full Text] [Related]  

  • 16. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal harm reduction among intravenous drug users.
    Kongsakon R; Pocham N
    J Med Assoc Thai; 2006 Sep; 89(9):1545-50. PubMed ID: 17100399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda.
    Vlahov D
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S3-6. PubMed ID: 7865324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.
    Hilton BA; Thompson R; Moore-Dempsey L; Janzen RG
    J Adv Nurs; 2001 Feb; 33(3):357-70. PubMed ID: 11251723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.